tumor supressor genes (Introgen)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Nametumor supressor genes (Introgen)
Drug Alias NameDOTAP-delivered tumor suppressor genes (Introgen)DOTAP:cholesterol-FHITDOTAP:cholesterol-p53
ClassificationBiologics
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsLung Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesIntrogen Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIntrogen Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsLung Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A